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Abstract
Background: Pernicious anaemia is undeniably associated with vitamin B12 deficiency, but the association between 
subnormal vitamin B12 concentrations and anaemia in older people is unclear. The aim of this systematic review was to 
evaluate the association between subnormal vitamin B12 concentrations and anaemia in older people.
Methods: Clinical queries for aetiology and treatment in bibliographic databases (PubMed [01/1949-10/2009]; 
EMBASE [01/1980-10/2009]) were used. Reference lists were checked for additional relevant studies. Observational 
studies (≥50 participants) and randomized placebo-controlled intervention trials (RCTs) were considered.
Results: 25 studies met the inclusion criteria. Twenty-one observational cross-sectional studies (total number of 
participants n = 16185) showed inconsistent results. In one longitudinal observational study, low vitamin B12 
concentrations were not associated with an increased risk of anaemia (total n = 423). The 3 RCTs (total n = 210) were 
well-designed and showed no effect of vitamin B12 supplementation on haemoglobin concentrations during follow-
up in subjects with subnormal vitamin B12 concentrations at the start of the study. Due to large clinical and 
methodological heterogeneity, statistical pooling of data was not performed.
Conclusions: Evidence of a positive association between a subnormal serum vitamin B12 concentration and anaemia 
in older people is limited and inconclusive. Further well-designed studies are needed to determine whether subnormal 
vitamin B12 is a risk factor for anaemia in older people.
Background
Pernicious anaemia is a form of anaemia that is undeni-
ably associated with vitamin B12 deficiency. Finding the
cure for pernicious anaemia even led to the discovery of
vitamin B12 [1-7]. Nowadays, vitamin B12 deficiency is
not only associated with (pernicious) anaemia, but is also
linked with other conditions such as dementia, neuropa-
thy and subacute combined degeneration of the spinal
cord [8-11]. Therefore, individuals with low serum con-
centrations of vitamin B12 are frequently given vitamin
B12 supplements [10-12]. Also, since low serum vitamin
B12 concentrations are very common in older individuals
[13], screening older people for vitamin B12 deficiency
has often been recommended [14,15].
Although the biological role of vitamin B12 in hae-
matopoiesis is well-defined [11,16-18], the outcomes of
some studies cast doubt on the relationship between low
vitamin B12 concentrations and anaemia in older individ-
uals [19,20]. The association between low vitamin B12
and anaemia has become even more difficult to study
because various cut-off values for serum vitamin B12 are
used and serum concentrations of vitamin B12 appear
not to be an accurate reflection of vitamin B12 status at
the tissue level [8,21,22].
Therefore, in order to evaluate the association between
subnormal vitamin B12 concentrations and anaemia in
older subjects, we performed a systematic review of rele-
vant observational (cross-sectional and longitudinal)
studies and randomized placebo-controlled trials that
have been published in the medical literature to date.
Methods
Criteria for considering studies for this review
All published cross-sectional and longitudinal observa-
tional studies in older individuals (mean or median age
≥60 years) on the association between vitamin B12 and
anaemia were considered for inclusion in this review. The
exact definitions of vitamin B12 deficiency and anaemia
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had to be clearly stated. Observational studies with less
than 50 participants were excluded.
In addition, we considered all randomized controlled
trials (RCTs) where subjects 60 years of age and over were
treated with vitamin B12 (any dose and any form of
administration) and were compared with subjects who
were given a placebo. Studies in which patients had
received vitamin B12 treatment prior to the study were
excluded. Trials in which combinations of vitamin B12
and folic acid were administered were also excluded.
Search strategy
We used predefined clinical queries (both sensitive and
specific) for aetiology and treatment as provided in
PubMed (January 1949 - October 2009) and EMBASE
(January 1980 - October 2009) using relevant MeSH-
headings and free text words for vitamin B12 and anae-
mia. Case reports and letters were excluded. We
restricted our search to articles published in English,
French, German and Dutch. The exact search strategies
are presented in Additional file 1 (PubMed) and Addi-
tional file 2 (EMBASE). Articles in which the mean or
median age of the study population was less than 60 years
were excluded by hand during the selection process.
Selection of studies
All titles and abstracts retrieved from the electronic data-
bases were initially assessed by the first author. In cases of
uncertainty of relevance, the titles and abstracts were also
independently assessed by the second author. Disagree-
ment was resolved by consensus. Full copies were
obtained for papers that were potentially relevant to our
review. Both authors independently assessed these papers
and disagreement was again resolved by consensus. Fur-
thermore, reference lists given in the full papers were
scrutinized by the first author for additional relevant
studies.
Data extraction
From the papers describing observational studies, (i)
mean/median (SD) vitamin B12 concentrations in anae-
mic and non-anaemic older subjects, (ii) mean/median
(SD) haemoglobin concentrations in older subjects with
vitamin B12 deficiency and subjects with normal vitamin
B12 concentrations, (iii) percentage of subjects with vita-
min B12 deficiency in anaemic and non-anaemic older
subjects, (iv) percentage of subjects with anaemia in vita-
min B12 deficient and non-deficient older subjects, or (v)
the correlation between vitamin B12 concentrations and
haemoglobin concentrations were extracted. Data
describing the correlation between vitamin B12 concen-
trations and mean corpuscular volume (MCV) or macro-
cytosis were also extracted, if available. From the papers
d e s c r i b i n g  i n t e r v e n t i o n  s t u d i e s ,  w e  e x t r a c t e d  p r e -  a n d
post-treatment mean haemoglobin concentrations, mean
proportions of haematocrit and mean MCV, or the
change in these variables during treatment. Measures of
association between low vitamin B12 concentrations and
anaemia and mean corpuscular volume (MCV), and indi-
cators of statistical significance were also extracted.
Quality assessment and level of evidence
The first and second author independently assessed the
quality of every included study. The included longitudinal
study that had been performed by our own research
group was also independently assessed by an indepen-
dent investigator (DAWM van der Windt). Disagreement
was resolved by consensus.
The methodological quality assessment of the observa-
tional studies was based on previously developed check-
lists for such studies [23,24]. For the cross-sectional
observational studies, we only used items on the check-
lists relevant to the quality assessment of cross-sectional
studies, including the use of valid selection criteria, a
response of ≥80%, the use of a valid and reproducible
method to assess the exposure, the use of a valid and
reproducible method to assess the outcome, the use of
new and incident patients, adjustment for possible con-
founders, and the inclusion of more than 100 subjects.
One point was awarded for each question that was
answered by 'yes'. The answers 'no' or 'unknown' were
given 0 points. The maximum total score possible for
cross-sectional studies was 7 points. Cross-sectional
studies that scored 5 points or more in terms of their
quality assessment were considered 'high quality'.
For the longitudinal studies, we added two items to the
quality assessment, namely a response at main moment
of follow-up ≥80%, and data collection for ≥1 year.
Again, one point was awarded for each question that
was answered by 'yes' and the answers 'no' or 'unknown'
were given 0 points. The maximum total score possible
for longitudinal studies was 9 points. Longitudinal studies
that scored 7 points or more in their quality assessment
were considered 'high quality'.
The quality assessment of the intervention studies was
carried out according to the criteria developed by Jadad
and colleagues [25]. This checklist includes three main
questions on the reporting of randomization, blinding,
and withdrawals and dropouts.
For each question that was answered by 'yes', one point
was awarded. An additional point was given if the
method used to generate the sequence of randomization
was described and was appropriate or if the method of
double blinding was described and was appropriate. One
point was deducted if the method to generate the
sequence of randomization was described and it was
inappropriate or if the method of double blinding was
described and it was inappropriate. The maximum total
score possible was 5 points. Intervention studies whichden Elzen et al. BMC Geriatrics 2010, 10:42
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scored 3 points or more for their quality assessment were
considered 'high quality'.
The level of evidence for the association between a sub-
normal vitamin B12 and anaemia was graded according
to the criteria described by the GRADE working group,
separately for the observational studies and the interven-
tion studies [26].
Results
Selection of studies
Electronic searches of PubMed and EMBASE databases
identified 3084 titles and abstracts of papers relevant to
the present review. We obtained 350 full papers; 21 of
which met our inclusion criteria. Four additional papers
were obtained by examining the reference lists given in
these chosen papers. A schematic representation of the
search process is described in Figure 1.
Observational studies
Twenty-one cross-sectional observational studies with a
total number of 16185 participants were included (Table
1) [27-47]. Eleven studies included participants from the
general population [27-37]. Ten studies investigated the
association between vitamin B12 and anaemia in hospi-
talized or institutionalized subjects [38-47]. Detailed
information about the studies can be found in Additional
file 3.
We did not try to retrieve a pooled estimate of the
results of the cross-sectional studies for the following rea-
sons: 1) the studies had been performed in very different
patient populations, 2) the investigators had used differ-
ent cut-off points for vitamin B12 deficiency and anae-
mia, 3) different effect estimates had been calculated and
4) the overall methodological quality was poor. This clini-
cal and methodological heterogeneity could not be solved
by any subgroup analysis.
Of the 21 observational cross-sectional studies, 8 stud-
ies were of low quality ("see Additional file 4")
[30,32,37,42-44,46,47]. The remaining 13 studies of high
quality differed substantially in sample size, criteria for
low vitamin B12 status and level of adjustment for con-
founders [27-29,31,33-36,38-41,45]. The studies showed
inconsistent results with regards to the association
between subnormal vitamin B12 concentrations or vita-
min B12 deficiency and anaemia in older subjects. In
three studies, an association between subnormal vitamin
B12 and anaemia was found (Clarke et al [29], Morris et
al. [36] and Wang et al [46]). For seven studies, the pres-
ence of an association was not clear because conflicting
findings regarding the presence of an association were
reported (Allain et al. [27], Johnson et al. [32], McLennan
et al. [35], Penninx et al. [37], Joosten et al. [40], Kwok et
al. [41], and Prayaharong et al. [44]). Eleven studies did
not find an association between subnormal vitamin B12
and anaemia (Bjorkegren et al. [28], Hin et al. [30], Hvas
et al. [31], Lippi et al. [33], Loikas et al. [34], Bisbe et al.
[38], Chui et al. [39], Metz et al. [42], Mooney et al. [43],
Stott et al. [45], and Witte et al. [47]).
Allain et al., McLennan et al. and Joosten et al. had
applied the lowest serum vitamin B12 cut-off points for
vitamin B12 deficiency (100 pg/mL, 140 pg/mL and 110
pmol/L respectively) [27,35,40]. In these three studies,
the presence of an association between vitamin B12 defi-
ciency and anaemia was not clear, because conflicting
findings regarding the presence of an association were
reported [27,35,40]. In the two largest population-based
studies by Clarke et al. and Morrison et al., subjects with
low vitamin B12 concentrations had an increased risk of
having anaemia, also after extensive adjustment for con-
founders [29,36], but an even larger study in hospitalized
older persons by Chui et al. did not show any association
between vitamin B12 deficiency and anaemia [39]. Simi-
lar inconsistencies were found with respect to the associ-
ation between subnormal vitamin B12 concentrations
and MCV.
Our own study appeared to be the only longitudinal
study on the effect of low vitamin B12 concentrations
(<150 pmol/L) on developing anaemia in a population-
based sample of 85-year-old subjects (n = 423) [48].
Detailed information about the study and the quality
assessment can be found in Additional file 5 and Addi-
tional file 6, respectively. After adjustment for possible
confounding variables, low vitamin B12 concentrations
were not associated with an increased risk of having
anaemia at baseline (prevalent anaemia) or developing
anaemia during follow-up (incident anaemia, Table 1).
Intervention studies
We found three randomized placebo-controlled trials
with a total number of 210 participants that met the
inclusion criteria for intervention studies for our review
(Table 2) [49-51]. Detailed information about the trials
can be found in Additional file 7. These three trials
included patients with low or subnormal vitamin B12 lev-
els concentrations at the start of the study. The first trial
by Hughes and colleagues included a random sample of
39 persons aged ≥65 years registered at general practices
in a town in Wales, UK, that were treated for 4 weeks
with intramuscular hydroxocobalamin or placebo. Hae-
moglobin was measured after 5 weeks [49]. The second
trial by Hvas et al. included 140 persons in Aarhus, Den-
mark, with elevated methylmalonic acid levels (median
age 75 years in the treatment group and 74 years in the
placebo group) that received weekly intramuscular injec-
tions of cyanocobalamin of placebo for 1 month. Haemo-
globin was measured after 3 months (13 weeks) [50]. In
the third trial by Seal and colleagues, 31 persons in two
geriatric hospitals in Melbourne, Australia, (mean ageden Elzen et al. BMC Geriatrics 2010, 10:42
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≥78 years) received two different doses of oral cyanoco-
balamin daily or placebo for 4 weeks [51].
Due to clinical heterogeneity (differences in methods of
administration, dose of vitamin B12, outcome measures
and treatment follow-up time) we did not combine the
results in a meta-analysis. However, all three RCTs, of
which two were regarded high quality ("see Additional
file 8") [49,50], showed no beneficial effect of vitamin B12
administration on haemoglobin concentrations and
MCV. In the study by Hughes et al, there was, on average,
a small decrease in haemoglobin level during the trial but
the difference between the mean changes in those given
vitamin B12 and those given placebo was very small and
not statistically significant [49]. In the study by Hvas et al,
the change in haemoglobin level was the same in the vita-
min B12 group and placebo group [50]. In addition, no
differences were observed in the mean change in haemo-
globin level in the three treatment groups in the study by
Seal et al. [51].
Level of evidence
Because of serious limitations of study quality and impor-
tant inconsistency of the observational studies, the level
of evidence for an association between subnormal vita-
min B12 concentrations and anaemia in older individuals
was considered low. Since the quality of two of the RCTs
was considered high, the level of evidence for the lack of
effect of vitamin B12 administration on haemoglobin in
older persons with low vitamin B12 concentrations at the
start of the study was considered high.
Discussion
Although anaemia is regarded as a classic complication of
vitamin B12 deficiency in older people [8,9,11], this sys-
tematic review showed that evidence for an association
Figure 1 Schematic representation of the selection of publications for review.
PubMed n=2201  EMBASE n=1257 
Titles and abstracts n=3084 
Full paper n=350 
Inclusion n=25 
Excluded: 
- Age n=524 
- Irrelevant or review n=2210 
Excluded: 
- Age n=81 
- Review n=49 
- Irrelevant n=106 
- Combination therapy n=10 
- Case report n=22 
- Prior treatment (trials) n=6 
- Identical data n=2 
- <50 participants n=49 
- No (placebo)control group n=4 
Reference list checking n=4
Observational studies n=22 
- Cross-sectional n=21 
- Longitudinal n=1 
Intervention studies n=3 
Duplicates n=374 den Elzen et al. BMC Geriatrics 2010, 10:42
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Table 1: Summary of the results and quality assessment of the observational studies included in this review
Author Year of 
publication
Sample 
size (N)
Age of subjects 
(years)
Study population Presence of an 
association 
between subnormal 
vitamin B12 and 
anaemia
Quality 
of study*
Cross-sectional
Population-based
Allain [27] 1997 233 ≥60, median 72 Random sample of older Zimbabweans 
(rural and urban).
?5
Björkegren [28] 2001 224 ≥70, mean 78.0 
(95% CI 77.2-78.9)
Random sample of persons aged 70 years 
and over in the Borough of Älvkarleby in 
the county of Uppsala, Sweden
-6
Clarke [29] 2008 2257 ≥65, mean 79.2 
(SD 6.2)
Oxford Healthy Aging Project: Random 
sample from general practice registers of 
people ≥65 years living in Oxford, UK. 
Banbury B12 Study: Random sample of 
people aged ≥75 years living in their own 
homes and registered with general 
practices in Banbury, Oxfordshire, UK.
+6
Hin [30] 2006 1000 ≥75, mean 81.4 
(SD 4.6)
Random sample of people ≥75 years 
living at home, registered with general 
practitioners in Banbury, England
-4
Hvas [31] 2005 937 Median 72, range 
19-102
Subjects with increased MMA (>0.28 
μmol/L) within in Aarhus, Denmark, from 
1995-2000.
-5
Johnson [32] 2003 103 ≥60, mean 76.4 
(SD 8.1)
Older individuals enlisted in nutrition 
service program in rural northeast 
Georgia, USA.
?4
Lippi[33] 2009 878 Range 85-101 Unselected subjects older than 85 years, 
who were referred by general 
practitioners to a laboratory in Verona, 
Italy, for routine diagnostic check-up 
over a period of 2 years
-6
Loikas [34] 2007 1048 ≥65, 37% ≥75 Lieto study; unselected population based 
health survey in Lieto, Finland.
-6
McLennan [35] 1973 347 >65 Random sample of people >65 years 
living at home in Kilsyth and Northern 
Glasgow, UK.
?5
Morris [36] 2007 1459 ≥60, mean 70 
(SEM 0.32)
Non-institutionalized civilian population 
(NHANES), USA.
+5
Penninx [37] 2000 700 ≥65, mean 77.3 Physically disabled older women living in 
the community (Women's Health and 
Ageing Study), Baltimore area, USA
?4den Elzen et al. BMC Geriatrics 2010, 10:42
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Hospitalized/Institutionalized
Bisbe[38] 2009 599 Mean 68 (SD 13) All consecutive patients scheduled for 
major orthopaedic surgery for which 
blood was routinely grouped 
preoperatively in University Hospital in 
Barcelona, Spain.
-5
Chui [39] 2001 3453 48% >70 All patients admitted to the Prince of 
Wales hospital, Hong Kong, with vitamin 
B12 measurements in 1996.
-5
Joosten [40] 1990 292 >65 Consecutive patients admitted to the 
geriatric department of the University 
Hospital, Leuven, Belgium
?5
Kwok [41] 2002 96 >55, mean age 
>78.0
Female ambulatory vegetarians (>3 
years) in Hong Kong.
?5
Metz [42] 1996 94 Cases: mean 79.8 
Controls: mean 
80.7
Patients with suspected low vitamin B12 
levels based on clinical examination by 
attending staff in Royal Melbourne and 
North West hospitals, Australia. If low 
vitamin B12: case. If normal vitamin B12: 
control.
-2
Mooney [43] 2004 905 65-85 Hospitalized patients in Belfast, Ireland, 
who had vitamin B12, folate, Hb, MCV 
and ferritin measured within ±4 days of 
each other in February-July 2003
-3
Prayurahong 
[44]
1993 147 ≥60 Subjects visiting clinic for older 
individuals in Rajvithi Hospital, Bangkok
?3
Stott [45] 1997 290 Range 62-110 Consecutive new referrals to a geriatric 
medical unit in Glasgow, Scotland.
-5
Wang [46] 2009 827 Mean 77.1 (SD 
7.5), range 60-96
Patients in the department of Neurology 
of Shanghai Punan Hospital, Shanghai, 
China.
+4
Witte [47] 2004 296 Mean 72.5 (10.3) Consecutive patients with chronic heart 
failure attending a heart failure clinic in 
Cottingham, UK
-4
Longitudinal
Den Elzen [48] 2008 423 85 All 85-year-old inhabitants of Leiden, the 
Netherlands. Participants using vitamin 
B12 or folate supplements at baseline or 
during follow-up were excluded.
-7
*Based on checklists from van der Windt et al [23,24]. Higher scores indicate higher quality (range cross-sectional studies 0-7; longitudinal studies 
0-9). Cross-sectional studies that scored 5 points or more were considered 'high quality'. Longitudinal studies that scored 7 points or more were 
considered 'high quality'.
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Table 2: Summary of the results and quality assessment of the intervention studies included in this review
Author Year of 
publication
Sample 
size (N)
Age of subjects 
(years)
Study population Intervention Effectiveness of 
vitamin B12 
treatment on 
haemoglobin 
concentrations
Quality of 
study*
Hughes [49] 1970 Placebo n = 19, 
Treatment n = 20
≥ 65 Random sample of subjects aged ≥65 years 
from general practices in a town in Wales, UK. 
Subjects with vitamin B12 level <150 pg/mL 
were invited to participate in the trial. None 
had anaemia or evidence of vitamin B12 
neuropathy and none was taking drugs that 
might interfere with vitamin B12 assays or 
anticonvulsants that might reduce the serum 
vitamin B12 level.
Intramuscular 
hydroxocobalamin (1000 μg), 
twice in the first week, and then 
at weekly intervals for a further 
four weeks or placebo 
containing a matching solution 
of phenol red 
(phenylsulphonphtalein 
0.075%)
-4  p o i n t s
Hvas [50] 2001 Placebo n = 70, 
treatment n = 70
Treatment group: 
Median 75 (range 
19-92) Placebo 
group: 74 (range 
33-88)
140 subjects in Aarhus, Denmark, with 
elevated methylmalonic acid (P-MMA, 0.40-
2.00 μmol/L) which had not received prior 
vitamin B12 treatment. Participants were 
enrolled between November 1998 and March 
2000. Exclusion criteria: low Hb levels, low 
ferritin levels, TSH≥4.1 mIU/L, high creatinine 
levels, life-threatening disease, treatment with 
anticoagulants, tropical atoxic neuropathy.
Weekly intramuscular injections 
of 1 mg cyanocobalamin (n = 70) 
or placebo containing 1 mL of 
isotonic sodium chloride (n = 70) 
for 1 month
-4  p o i n t s
Seal [51] 2002 Placebo n = 11, oral 
vitamin B12 10 μg n = 
10, oral vitamin B12 
50 μg, n = 10
Mean age 
placebo 78, 
vitamin B12 10 μg 
82, vitamin B12 
50 μg 85
31 patients in two geriatric hospitals in 
Melbourne, Australia with subnormal serum 
vitamin B12 (100-150 pmol/L) discovered as 
part of their clinical assessment. Exclusion 
criteria: known neoplasm, life-threatening or 
terminal illness, history of malabsorption, 
pernicious anaemia, anaemia of other cause, 
prior vitamin B12 treatment or vitamin 
supplementation, neurological disorder other 
than stroke.
Placebo (Australian 
Pharmaceutical Formulary (APF) 
red mixture and APF 
hydrobenzoate compound), 10 
μg oral cyanocobalamin or 50 
μg oral cyanocobalamin daily 
for 4 weeks
-2  p o i n t s
**Based on checklist from Jadad et al. [25] Higher scores indicate higher quality (range 0-5). Intervention studies that scored 3 points or more were considered 'high quality'.den Elzen et al. BMC Geriatrics 2010, 10:42
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between a subnormal serum vitamin B12 concentration
and anaemia in older people is limited and inconclusive.
A total of 21 observational cross-sectional studies
included in our review showed inconsistent results [27-
47]. Similar inconsistencies were found with respect to
the association between subnormal vitamin B12 concen-
trations and MCV. We identified one longitudinal obser-
vational study in older subjects in the general population,
in which low vitamin B12 concentrations were not associ-
ated with an increased risk of developing anaemia or the
change in MCV over time [48]. Interestingly, the three
included RCTs, of which two were regarded as high qual-
ity RCTs, showed no effect of vitamin B12 administration
on haemoglobin concentrations and MCV in subjects
with subnormal vitamin B12 concentrations at the start
of the study [49-51], which is unlikely to be explained by
insufficient dose of vitamin B12 supplementation, since
the RCTs did show changes in vitamin B12, homo-
cysteine and MMA concentrations.
This lack of effect of vitamin B12 treatment on haemo-
globin concentrations and MCV in patients with low or
subnormal vitamin B12 concentrations is surprising,
especially since vitamin B12 has such a well-defined role
in haematopoiesis [11,16-18]. However, our results are in
line with a systematic review by Oosterhuis and co-work-
ers that showed that the diagnostic value of the mean cor-
puscular volume in the detection of vitamin B12
deficiency is poor [52]. There are two possible explana-
tions why evidence of an association between subnormal
vitamin B12 concentrations and anaemia is lacking. First,
the studies included in the review had used many differ-
ent tests to measure the concentration of serum vitamin
B12, ranging from microbiological assays with L. leich-
mannii to radio immunoassays, and had applied different
cut-off points for vitamin B12 deficiency. This may have
led to misclassification in the diagnosis of vitamin B12
deficiency and, as a result, to dilution of the association
between vitamin B12 deficiency and anaemia. However,
the 3 studies that had applied the lowest cut-off point for
vitamin B12 deficiency, in which therefore the strongest
a s s o c i a t i o n s  w e r e  t o  b e  e x p e c t e d ,  d i d  n o t  r e p o r t  c l e a r
associations between vitamin B12 deficiency and anae-
mia [27,35,40]. The second explanation is that a subnor-
mal vitamin B12 concentration alone is not a sufficient
cause to develop anaemia. Other genetic or environmen-
tal factors may be necessary to develop anaemia in the
presence of subnormal vitamin B12 concentrations. A
similar explanation has been proposed for the lack of
association between the C282Y mutation of the heredi-
tary haemochromatosis gene and mortality in old age
[53].
Several difficulties were encountered when conducting
this systematic review. These are similar to the problems
Oosterhuis and co-workers faced when writing their sys-
tematic review on the diagnostic accuracy of the mean
corpuscular volume in the detection of vitamin B12 defi-
ciency [52]. Most importantly, the relation between low
vitamin B12 concentrations and anaemia was not an
explicit research question in most of the studies included
in the present review, which could have resulted in insuf-
ficient statistical power to detect an association.
The diagnosis of vitamin B12 deficiency is a major con-
cern in medical literature and its difficulties have been
addressed thoroughly by others in the field [9,54]. Our
systematic literature search identified only 25 relevant
studies to review the association between vitamin B12
and anaemia in older people. In those studies many dif-
ferent assays were used to measure vitamin B12 and hae-
moglobin concentrations and varying cut-off points were
applied to define vitamin B12 deficiency and anaemia.
This considerably limited the comparability of the studies
and emphasizes the need for a clear and globally used
definition of (sub)normal vitamin B12 concentrations,
either based on serum vitamin B12 concentrations alone,
or in combination with elevated homocysteine or methyl-
malonic acid concentrations [9].
Furthermore, the clinical and methodological heteroge-
neity in the included observational studies prevented us
from performing statistical pooling of data and thus
drawing definite conclusions. The participation rates and
adjustments for potential confounders, in particular, war-
rant improvement in future observational studies. We
identified only one longitudinal study on this topic.
Although this longitudinal study did not show any associ-
ation between low serum vitamin B12 concentrations and
the future development of anaemia, this study involved
subjects aged 85 years only and has to be replicated in
younger age groups (60-85 years) before more definite
conclusions can be drawn.
We found 3 placebo-controlled trials meeting our
inclusion criteria. Participants in these trials received
vitamin B12 supplements for 4 weeks and were only fol-
lowed for 1 to 3 months. Randomized placebo-controlled
trials with longer treatment and longer follow-up periods
are needed, because the effects of vitamin B12 supple-
mentation on haemoglobin concentrations may only
become apparent after 3 months.
Although we did not find an association between sub-
normal vitamin B12 concentrations and anaemia in older
people, this does not imply that patients with pernicious
anaemia or age-related food-vitamin B12 malabsorption
(with tissue depletion of vitamin B12 and very low vita-
min B12 concentrations) will not benefit from vitamin
B12 administration, especially since non-placebo-con-
trolled studies showed (large) increases in haemoglobin
concentrations or haematocrit after intramuscular or oral
vitamin B12 administration in patients with pernicious
anaemia or age-related food-vitamin B12 malabsorptionden Elzen et al. BMC Geriatrics 2010, 10:42
http://www.biomedcentral.com/1471-2318/10/42
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[55-59]. However, apart from the undisputed reality of
pernicious anaemia, the clinical impact of a subnormal
vitamin B12 level in older people is unclear, especially
since several observational studies and randomized con-
trolled trials also showed no effect of vitamin B12 admin-
istration on cognitive function [60-62].
Conclusions
The studies included in this systematic review indicate
that evidence of an association between a subnormal
serum vitamin B12 concentration and anaemia in older
people is limited and inconclusive. If anything, given the
high clinical relevance of our research question, we rec-
ommend more well-designed longitudinal observational
studies, in younger age groups (60-85 years) especially,
and intervention studies of appropriate size and duration
with timely follow-up periods to determine whether a
subnormal vitamin B12 is a risk factor for anaemia in
older people.
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